Table 1.
Quarterly consumption of representative antibiotics and antibacterial compound classes
| Time | DDD/1000 patient-days | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Penicillins | Cephalosporins | Carbapenems | Fluoroquinolones | Aminoglycosides | Other | Piperacillin + tazobactam | Ampicillin + enzyme inhibitors | Amoxicillin + enzyme inhibitors | Ceftriaxone | Cefuroxime | Imipenem + enzyme inhibitor | Meropenem | Ertapenem | |
| Quarter I 2012 | 27.66 | 352.71 | 184.89 | 72.38 | 12.44 | 218.81 | 27.66 | 0.00 | 0.00 | 341.92 | 2.37 | 66.01 | 64.70 | 54.18 |
| Quarter II 2012 | 36.99 | 265.39 | 183.44 | 81.03 | 29.42 | 242.46 | 10.69 | 18.33 | 7.96 | 222.05 | 35.42 | 58.73 | 74.24 | 50.47 |
| Quarter III 2012 | 151.70 | 266.49 | 245.93 | 126.71 | 27.72 | 319.52 | 13.40 | 122.35 | 8.01 | 199.17 | 52.86 | 93.63 | 92.09 | 60.20 |
| Quarter IV 2012 | 60.22 | 231.60 | 159.33 | 77.81 | 23.55 | 246.94 | 21.00 | 39.22 | 0.00 | 191.74 | 36.19 | 67.68 | 77.88 | 13.76 |
| Quarter I 2013 | 118.27 | 184.84 | 222.13 | 73.13 | 8.29 | 273.84 | 53.35 | 50.48 | 7.53 | 99.17 | 73.45 | 64.67 | 113.67 | 43.79 |
| Quarter II 2013 | 110.80 | 148.78 | 210.68 | 80.47 | 21.77 | 346.61 | 32.67 | 60.68 | 13.63 | 81.03 | 55.82 | 70.31 | 90.73 | 49.64 |
| Quarter III 2013 | 138.16 | 232.97 | 270.24 | 77.04 | 25.98 | 339.51 | 71.43 | 57.50 | 8.76 | 137.83 | 63.18 | 55.34 | 172.22 | 42.67 |
| Quarter IV 2013 | 139.90 | 241.57 | 286.46 | 88.46 | 40.49 | 468.93 | 102.33 | 36.05 | 0.00 | 127.11 | 17.71 | 97.50 | 165.75 | 23.21 |